Cargando…
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
Breast cancer is the leading cause of death among women worldwide. Despite the recent treatment options like surgery, chemotherapy etc. the lethality of breast cancer is alarming. Natural compounds are considered a better treatment option against breast carcinoma because of their lower side effects...
Autores principales: | Qayoom, Hina, Alkhanani, Mustfa, Almilaibary, Abdullah, Alsagaby, Suliman A., Mir, Manzoor Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329161/ https://www.ncbi.nlm.nih.gov/pubmed/37425621 http://dx.doi.org/10.1016/j.sjbs.2023.103705 |
Ejemplares similares
-
Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation
por: sofi, Shazia, et al.
Publicado: (2023) -
Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation
por: Qayoom, Hina, et al.
Publicado: (2023) -
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022) -
Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma
por: Mir, Wajahat Rashid, et al.
Publicado: (2023) -
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
por: Mehraj, Umar, et al.
Publicado: (2022)